Literature DB >> 17683188

Prostatic intraepithelial neoplasia: recent advances.

Alberto G Ayala1, Jae Y Ro.   

Abstract

CONTEXT: There have been 2 putative prostatic cancer precursors, prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (adenosis), but PIN remains as a well-known precancerous condition.
OBJECTIVE: To describe recent advances in knowledge of PIN and to better define the diagnostic criteria and differential diagnosis of PIN. DATA SOURCES: Review of the pertinent literature and our experience.
CONCLUSIONS: The presence of ductal/acinar epithelial changes including nuclear enlargement, prominent nucleoli, chromatin alterations, and luminal complexity is an easy way to identify the disorder. Four main patterns of high-grade PIN (HGPIN) have been described: tufting, micropapillary, cribriform, and flat. In addition, variants of HGPIN have also been described. Both HGPIN and prostatic carcinoma share an increased incidence and severity with advancing age and with high rates of occurrence in the peripheral zone of the prostate. Furthermore, HGPIN and prostate cancer share genetic and molecular markers as well, with PIN representing an intermediate stage between benign epithelium and invasive carcinoma. The clinical significance of HGPIN is that it identifies patients at risk for prostatic carcinoma. With the increased use of extended biopsy protocols, clinicians are more likely to identify HGPIN and less likely to miss concurrent carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17683188     DOI: 10.5858/2007-131-1257-PINRA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

Review 1.  What is the pathologist saying? Interpretation of the prostate pathology report.

Authors:  Omar Hameed
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

Review 2.  The reactive stroma microenvironment and prostate cancer progression.

Authors:  David A Barron; David R Rowley
Journal:  Endocr Relat Cancer       Date:  2012-10-30       Impact factor: 5.678

3.  New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Yu-Jia Chang; Chin-Ying Chung; Shinichi Yamashita; Lei Li; Soo Ok Lee; Shuyuan Yeh; Chawnshang Chang
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

4.  Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer.

Authors:  Bing Yang; Sachin Bhusari; Jessica Kueck; Pushpa Weeratunga; Jennifer Wagner; Glen Leverson; Wei Huang; David F Jarrard
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

5.  Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.

Authors:  Ahmed Abdel-Hady; Ali El-Hindawi; Olfat Hammam; Heba Khalil; Sara Diab; Soulafa Abd El-Aziz; Mohamed Badawy; Ahmed Ismail; Noha Helmy; Nora Kamel; Shady Anis; Amr El Kholy; Khalid Al Osili; Afaf Abdel-Hady; Hani Nour; Maha Akl
Journal:  Open Access Maced J Med Sci       Date:  2017-03-20

6.  ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients.

Authors:  Najla Aldaoud; Ashley Graboski-Bauer; Nour Abdo; Samir Al Bashir; Ashraf O Oweis; Hanadi Ebwaini; Yousef Hasen; Rami Alazab; Kiril Trpkov
Journal:  Res Rep Urol       Date:  2019-05-22

Review 7.  Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope.

Authors:  Sirin Saranyutanon; Sanjeev Kumar Srivastava; Sachin Pai; Seema Singh; Ajay Pratap Singh
Journal:  Cancers (Basel)       Date:  2019-12-23       Impact factor: 6.639

8.  Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

Authors:  Maddalena Barba; Li Yang; Holger J Schünemann; Francesca Sperati; Sara Grioni; Saverio Stranges; Kim C Westerlind; Giovanni Blandino; Michele Gallucci; Rossella Lauria; Luca Malorni; Paola Muti
Journal:  J Exp Clin Cancer Res       Date:  2009-10-08

9.  Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Authors:  Nagi Kumar; Ganna Chornokur
Journal:  Transl Med (Sunnyvale)       Date:  2012-12-31

10.  Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.

Authors:  Kunyoo Shin; Agnes Lim; Justin I Odegaard; Jared D Honeycutt; Sally Kawano; Michael H Hsieh; Philip A Beachy
Journal:  Nat Cell Biol       Date:  2014-04-20       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.